Sleep Aids Market

Sleep Aids Market Size by Product (Mattresses & Pillows, Medications, Sleep Apnea Devices and Others), Sleep Disorder (Insomnia, Narcolepsy, Restless Leg Syndrome, Sleep Apnea and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, E-commerce, Drug Stores and Others), Regions, Global Industry Analysis, Share, Growth, Trends, and Forecast 2023 to 2032

Base Year: 2022 Historical Data: 2019-21
  • Report ID: TBI-13768
  • Published Date: Oct, 2023
  • Pages: 239
  • Category: Healthcare
  • Format: PDF
Buy @ $4700.00 Request Sample PDF

The global sleep aids market generated USD 80.16 billion revenue in 2022 and is projected to grow at a CAGR of 7.04% from 2023 to 2032. The expansion of this market can be credited to several key factors, including the escalating incidence of sleep disorders, increasing awareness of the benefits associated with the use of sleep aids, and the continuous technological progress in sleep apnea devices. Furthermore, the mounting endorsements of these products, coupled with government funding to foster healthier approaches to sleep apnea diagnosis and treatment, are generating extensive prospects for sleep aid product manufacturers to combat chronic sleep-related conditions and expand their market presence.

Market Introduction:

Sleep aids are substances, medications, or devices designed to help individuals improve their sleep quality or manage sleep-related issues. These aids can encompass various products and techniques, including prescription and over-the-counter medications, herbal supplements, lifestyle changes, relaxation techniques, sleep hygiene practices, and specialized devices like sleep apnea machines or wearable sleep tracking technology. Their primary aim is to assist individuals in falling asleep more easily, staying asleep longer, and achieving restful and restorative sleep, thereby addressing various sleep-related problems and disorders. Prescription sleep aids are generally reserved for addressing more severe and chronic sleep disorders, and their usage necessitates a healthcare provider's prescription. On the other hand, over-the-counter sleep aids, like antihistamines and melatonin supplements, are readily accessible without a prescription and serve to induce relaxation and enhance the overall quality of sleep. An increasing number of individuals are turning to natural sleep aids, encompassing herbal supplements and essential oils, in their quest for holistic and organic methods to enhance sleep quality. These remedies have gained popularity as consumers seek alternatives to traditional medications. Moreover, sleep-tracking devices, from wearable gadgets to innovative smart pillows, have become valuable tools for monitoring sleep patterns. They allow users to assess their sleep quality and gain insights into potential factors affecting their sleep. These devices enable individuals to adjust their sleep hygiene by providing feedback and data analysis, ultimately promoting better sleep.

Sleep Aids Market Size

Get an overview of this study by requesting a free sample

Recent Development
  • In January 2023: LG Electronics has unveiled an innovative wireless earphone that enhances sleep quality through advanced brain wave technology. Developed under the wing of their subsidiary, SleepWave, this revolutionary device, known as "Breeze," goes beyond merely aiding sleep—it actively monitors and analyzes sleep data in real time, offering personalized recommendations for improved sleep patterns. The device is crafted to be comfortably worn during sleep. The Breeze earphone is a lightweight marvel that leverages brain wave-based technology to deliver synchronized sounds at varying frequencies. These encompass static and dynamic binaural beats, specifically aiming to induce brain waves conducive to sleep or facilitate a smooth transition into a deep slumber, typically characterized by brain waves operating within the 0.5-3 Hertz range. Moreover, the Breeze earphone boasts an extensive library of 80 pre-installed sounds, including brain wave-tuned compositions, lullabies, and the soothing sounds of nature, capable of triggering an Autonomous Sensory Meridian Response (ASMR). Beyond these options, the earphone seamlessly synchronizes with users' preferred music or videos from platforms like YouTube, further customizing the auditory experience for a peaceful night's sleep.
  • In October 2022: Pfizer Inc. has officially concluded its acquisition of Biohaven Pharmaceutical Holding Company Ltd., the renowned manufacturer of NURTEC ODT (rimegepant). This groundbreaking migraine therapy has garnered approval for its dual utility in acute treating and preventing episodic migraines among adults.
  • In August 2022: ResMed has disclosed its successful acquisition of Mementor, a Leipzig-based company. This strategic move bolsters ResMed's comprehensive sleep product offerings in Germany, introducing a digital solution tailored to address insomnia concerns.

Market Dynamics:

Drivers

Increasing Prevalence of Sleep Disorders - The rising incidence of sleep disorders such as insomnia, narcolepsy, sleep apnea, and others is driving the growth of the sleep aids market. As awareness of these conditions grows, more people seek medical help and medication to improve their sleep.

Stress and Lifestyle Factors - Modern lifestyles are often portrayed by high stress levels, irregular work hours, and excessive screen time, which can disrupt sleep patterns. These factors have increased the demand for sleep aids as individuals seek ways to manage their problems.

Older Adult Population - The global population is ageing, and elderly individuals are more prone to sleep-related issues. This demographic shift has created a larger customer base for sleep aid products.

Restraints:

Safety Concerns and Side Effects - Many sleep aids, especially prescription medications, can have side effects, including drowsiness, grogginess, dependency, and even the risk of addiction. This factor has raised safety concerns among both patients and healthcare professionals.

Regulatory Hurdles - Sleep aids, particularly prescription drugs, are subject to strict regulatory oversight. The approval process for new sleep aid medications can be time-consuming and costly, hindering market growth.

Opportunities:

Growing Awareness of Sleep Health - Increasing understanding of the significance of sleep in overall health and well-being presents a significant opportunity. More individuals are seeking information and solutions for improving their sleep, which can drive demand for sleep aids.

Innovative Products and Technologies - Advances in sleep aid technologies, such as wearable devices, smart beds, and mobile apps for tracking sleep patterns, offer opportunities to develop more effective and personalized solutions.

Natural and Non-Prescription Sleep Aids - The demand for natural and non-prescription sleep aid products is rising. This factor may create new opportunities for companies to develop and market non-pharmaceutical sleep remedies.

Challenges:

Limited Long-Term Efficacy - Some sleep aids work well in the short term, but their long-term efficacy can be limited. Patients may develop a tolerance, requiring higher doses or alternative treatments.

Cost and Accessibility - The cost of prescription sleep aids can be high, and not all insurance plans cover them. This financial barrier can discourage some individuals from seeking treatment.

Regional segmentation analysis:

The regions analyzed for the market include North America, Europe, South America, Asia Pacific, the Middle East, and Africa. The North American region emerged as the most prominent global sleep aids market, with a 42.29% market revenue share in 2022.

North America has a significant prevalence of sleep disorders, including insomnia, narcolepsy, restless leg syndrome, and others. This high prevalence drives the demand for sleep aids as individuals seek relief from their sleep-related problems. In addition, North America has growing awareness about the importance of quality sleep for overall health and well-being. Thus, more people sought medical help for sleep disturbances, resulting in higher sales of sleep aids. Furthermore, North America boasts a well-developed healthcare infrastructure, including a network of sleep clinics and specialist centers. This infrastructure supports diagnosing and treating sleep disorders, including prescription sleep aid medications. The region is also a hub for medical research and innovation. Ongoing research in sleep medicine has led to the developing of new and more effective sleep aid products. This innovation drives the growth of the sleep aids market. The European region held the second-highest market share in 2022. Modern lifestyles in Europe often involve high stress levels, irregular work hours, and excessive screen time, which can disrupt sleep patterns. These factors contribute to the demand for sleep aids. The European Union (EU) has a stringent regulative framework that assures the safety and efficacy of sleep aid products. This regulatory oversight provides consumers with confidence in the quality of the products. Besides, the availability of prescription and OTC sleep aid products in Europe provides consumers various options to manage their sleep disturbances.

North America Region Sleep Aids Market Share in 2022 - 42.29%

 

www.thebrainyinsights.com

Check the geographical analysis of this market by requesting a free sample

Product Segment Analysis

The product segment includes mattresses & pillows, medications, sleep apnea devices and others. The mattresses & pillows segment dominated the market, with a share of 41.57% in 2022. Mattresses and pillows are fundamental components of a good night's sleep. They provide comfort and support, ensuring that individuals can rest comfortably, essential for sleep quality. Many sleep disturbances can be traced back to uncomfortable or inadequate bedding. Additionally, mattresses and pillows have a broad appeal. They are essential for nearly everyone, regardless of whether they have a diagnosed sleep disorder. Therefore, there is a large potential customer base for products in this segment. Mattresses and pillows also typically have a longer lifespan than other sleep aid products. While medications and supplements are consumed and must be replaced, mattresses and pillows can last for years, making them a cost-effective long-term solution.

Sleep Disorder Segment Analysis

The sleep disorder segment is classified into insomnia, narcolepsy, restless leg syndrome, sleep apnea and others. The insomnia segment dominated the market, with a share of around 38.25% in 2022. Insomnia is a prevalent sleep disorder, impacting a significant portion of the population. This widespread occurrence drives the demand for sleep aid products, with many individuals seeking treatment to address their insomnia symptoms. Insomnia often prompts individuals to seek medical attention, leading to healthcare professionals' diagnosis and prescription of sleep aid medications. This medical intervention contributes to the dominance of insomnia in the sleep aids market. Besides, insomnia can be a chronic condition lasting for weeks, months, or even years. Individuals with chronic insomnia may require ongoing treatment, creating a consistent market for sleep aids.

Distribution Channel Segment Analysis

The distribution channel segment is split into hospital pharmacies, retail pharmacies, e-commerce, drug stores and others. The e-commerce segment dominated the market, with a share of around 26.94% in 2022. E-commerce platforms provide unparalleled convenience for consumers. Shoppers can browse and purchase sleep aids from the comfort of their homes, eliminating the need to visit physical stores. This accessibility is particularly important for individuals with sleep disturbances, as it allows them to shop anytime that suits their needs, including during nighttime. Moreover, e-commerce platforms offer many sleep aid products, including mattresses, pillows, over-the-counter medications, supplements, and sleep-related accessories. Consumers can compare and choose from various brands and product options, ensuring they find the sleep aid that best fits their requirements. Also, e-commerce websites often provide comprehensive product information and user reviews. These features empower consumers to decide which sleep aids suit their specific sleep-related issues. Reading reviews from other customers can instil confidence in the product's efficacy.

Some of the Key Market Players:
  • AstraZeneca Plc
  • Biodiem
  • BMC Medical Co., Ltd.
  • Cadwell Industries, Inc.
  • Compumedics Limited
  • Drive DeVilbiss Healthcare Inc.
  • Eisai Inc.
  • Fisher & Paykel Healthcare Limited
  • GlaxoSmithKline Plc
  • Idorsia Pharmaceuticals Ltd.
  • Koninklijke Philips N.V.
  • LG Electronics
  • Lowenstein Medical Technology GmbH
  • Merck& Co., Inc.
  • Natus Medical Inc.
  • Novartis AG
  • Pfizer, Inc.
  • ResMed Inc.
  • Rotech Healthcare Inc.
  • Sanofi S.A.
  • SleepMed Inc.
  • Simple Habit
  • StimScience
  • Takeda Pharmaceutical Company Limited

Report Description: 

Attribute Description
Market Size Revenue (USD Billion)
Market size value in 2022 USD 80.16 Billion
Market size value in 2032 USD 158.28 Billion
CAGR (2023 to 2032) 7.04%
Historical data 2019-2021
Base Year 2022
Forecast 2023-2032
Region The regions analyzed for the market are Asia Pacific, Europe, South America, North America, and Middle East & Africa. Furthermore, the regions are further analyzed at the country level.
Segments Product, Sleep Disorder and Distribution Channel

Frequesntly Asked Questions

As per The Brainy Insights, the size of the sleep aids market was valued at USD 80.16 billion in 2022 to USD 158.28 billion by 2032.

The global sleep aids market is growing at a CAGR of 7.04% during the forecast period 2023-2032.

The North American region became the largest market for sleep aids.

Aging population and increasing prevalence of sleep disorders are influencing the market's growth.

1. Introduction
    1.1. Objectives of the Study
    1.2. Market Definition
    1.3. Research Scope
    1.4. Currency
    1.5. Key Target Audience

2. Research Methodology and Assumptions

3. Executive Summary

4. Premium Insights
    4.1. Porter’s Five Forces Analysis
    4.2. Value Chain Analysis
    4.3. Top Investment Pockets
          4.3.1. Market Attractiveness Analysis by Product
          4.3.2. Market Attractiveness Analysis by Sleep Disorder
          4.3.3. Market Attractiveness Analysis by Distribution Channel
          4.3.4. Market Attractiveness Analysis by Region
    4.4. Industry Trends

5. Market Dynamics
    5.1. Market Evaluation
    5.2. Drivers
          5.2.1. Increasing Prevalence of Sleep Disorders
          5.2.2. Stress and Lifestyle Factors
          5.2.3. Aging Population
    5.3. Restraints
          5.3.1. Safety Concerns and Side Effects
          5.3.2. Regulatory Hurdles
    5.4. Opportunities
          5.4.1. Growing Awareness of Sleep Health
          5.4.2. Innovative Products and Technologies
          5.4.3. Natural and Non-Prescription Sleep Aids
    5.5. Challenges
          5.5.1. Limited Long-Term Efficacy
          5.5.2. Cost and Accessibility

6. Global Sleep Aids Market Analysis and Forecast, By Product
    6.1. Segment Overview
    6.2. Mattresses & Pillows
    6.3. Medications
    6.4. Sleep Apnea Devices
    6.5. Others

7. Global Sleep Aids Market Analysis and Forecast, By Sleep Disorder
    7.1. Segment Overview
    7.2. Insomnia
    7.3. Narcolepsy
    7.4. Restless Leg Syndrome
    7.5. Sleep Apnea
    7.6. Others

8. Global Sleep Aids Market Analysis and Forecast, By Distribution Channel
    8.1. Segment Overview
    8.2. Hospital Pharmacies
    8.3. Retail Pharmacies
    8.4. E-commerce
    8.5. Drug Stores
    8.6. Others

9. Global Sleep Aids Market Analysis and Forecast, By Regional Analysis
    9.1. Segment Overview
    9.2. North America
          9.2.1. U.S.
          9.2.2. Canada
          9.2.3. Mexico
    9.3. Europe
          9.3.1. Germany
          9.3.2. France
          9.3.3. U.K.
          9.3.4. Italy
          9.3.5. Spain
    9.4. Asia-Pacific
          9.4.1. Japan
          9.4.2. China
          9.4.3. India
    9.5. South America
          9.5.1. Brazil
    9.6. Middle East and Africa
          9.6.1. UAE
          9.6.2. South Africa

10. Global Sleep Aids Market-Competitive Landscape
    10.1. Overview
    10.2. Market Share of Key Players in the Sleep Aids Market
          10.2.1. Global Company Market Share
          10.2.2. North America Company Market Share
          10.2.3. Europe Company Market Share
          10.2.4. APAC Company Market Share
    10.3. Competitive Situations and Trends
          10.3.1. Product Launches and Developments
          10.3.2. Partnerships, Collaborations, and Agreements
          10.3.3. Mergers & Acquisitions
          10.3.4. Expansions

11. Company Profiles
    11.1. AstraZeneca Plc
          11.1.1. Business Overview
          11.1.2. Company Snapshot
          11.1.3. Company Market Share Analysis
          11.1.4. Company Product Portfolio
          11.1.5. Recent Developments
          11.1.6. SWOT Analysis
    11.2. Biodiem
          11.2.1. Business Overview
          11.2.2. Company Snapshot
          11.2.3. Company Market Share Analysis
          11.2.4. Company Product Portfolio
          11.2.5. Recent Developments
          11.2.6. SWOT Analysis
    11.3. BMC Medical Co., Ltd.
          11.3.1. Business Overview
          11.3.2. Company Snapshot
          11.3.3. Company Market Share Analysis
          11.3.4. Company Product Portfolio
          11.3.5. Recent Developments
          11.3.6. SWOT Analysis
    11.4. Cadwell Industries, Inc.
          11.4.1. Business Overview
          11.4.2. Company Snapshot
          11.4.3. Company Market Share Analysis
          11.4.4. Company Product Portfolio
          11.4.5. Recent Developments
          11.4.6. SWOT Analysis
    11.5. Compumedics Limited
          11.5.1. Business Overview
          11.5.2. Company Snapshot
          11.5.3. Company Market Share Analysis
          11.5.4. Company Product Portfolio
          11.5.5. Recent Developments
          11.5.6. SWOT Analysis
    11.6. Drive DeVilbiss Healthcare Inc.
          11.6.1. Business Overview
          11.6.2. Company Snapshot
          11.6.3. Company Market Share Analysis
          11.6.4. Company Product Portfolio
          11.6.5. Recent Developments
          11.6.6. SWOT Analysis
    11.7. Eisai Inc.
          11.7.1. Business Overview
          11.7.2. Company Snapshot
          11.7.3. Company Market Share Analysis
          11.7.4. Company Product Portfolio
          11.7.5. Recent Developments
          11.7.6. SWOT Analysis
    11.8. Fisher & Paykel Healthcare Limited
          11.8.1. Business Overview
          11.8.2. Company Snapshot
          11.8.3. Company Market Share Analysis
          11.8.4. Company Product Portfolio
          11.8.5. Recent Developments
          11.8.6. SWOT Analysis
    11.9. GlaxoSmithKline Plc
          11.9.1. Business Overview
          11.9.2. Company Snapshot
          11.9.3. Company Market Share Analysis
          11.9.4. Company Product Portfolio
          11.9.5. Recent Developments
          11.9.6. SWOT Analysis
    11.10. Idorsia Pharmaceuticals Ltd.
          11.10.1. Business Overview
          11.10.2. Company Snapshot
          11.10.3. Company Market Share Analysis
          11.10.4. Company Product Portfolio
          11.10.5. Recent Developments
          11.10.6. SWOT Analysis
    11.11. Koninklijke Philips N.V.
          11.11.1. Business Overview
          11.11.2. Company Snapshot
          11.11.3. Company Market Share Analysis
          11.11.4. Company Product Portfolio
          11.11.5. Recent Developments
          11.11.6. SWOT Analysis
    11.12. LG Electronics
          11.12.1. Business Overview
          11.12.2. Company Snapshot
          11.12.3. Company Market Share Analysis
          11.12.4. Company Product Portfolio
          11.12.5. Recent Developments
          11.12.6. SWOT Analysis
    11.13. Lowenstein Medical Technology GmbH
          11.13.1. Business Overview
          11.13.2. Company Snapshot
          11.13.3. Company Market Share Analysis
          11.13.4. Company Product Portfolio
          11.13.5. Recent Developments
          11.13.6. SWOT Analysis
    11.14. Merck& Co., Inc.
          11.14.1. Business Overview
          11.14.2. Company Snapshot
          11.14.3. Company Market Share Analysis
          11.14.4. Company Product Portfolio
          11.14.5. Recent Developments
          11.14.6. SWOT Analysis
    11.15. Natus Medical Inc.
          11.15.1. Business Overview
          11.15.2. Company Snapshot
          11.15.3. Company Market Share Analysis
          11.15.4. Company Product Portfolio
          11.15.5. Recent Developments
          11.15.6. SWOT Analysis
    11.16. Novartis AG
          11.16.1. Business Overview
          11.16.2. Company Snapshot
          11.16.3. Company Market Share Analysis
          11.16.4. Company Product Portfolio
          11.16.5. Recent Developments
          11.16.6. SWOT Analysis
    11.17. Pfizer, Inc.
          11.17.1. Business Overview
          11.17.2. Company Snapshot
          11.17.3. Company Market Share Analysis
          11.17.4. Company Product Portfolio
          11.17.5. Recent Developments
          11.17.6. SWOT Analysis
    11.18. ResMed Inc.
          11.18.1. Business Overview
          11.18.2. Company Snapshot
          11.18.3. Company Market Share Analysis
          11.18.4. Company Product Portfolio
          11.18.5. Recent Developments
          11.18.6. SWOT Analysis
    11.19. Rotech Healthcare Inc.
          11.19.1. Business Overview
          11.19.2. Company Snapshot
          11.19.3. Company Market Share Analysis
          11.19.4. Company Product Portfolio
          11.19.5. Recent Developments
          11.19.6. SWOT Analysis
    11.20. Sanofi S.A.
          11.20.1. Business Overview
          11.20.2. Company Snapshot
          11.20.3. Company Market Share Analysis
          11.20.4. Company Product Portfolio
          11.20.5. Recent Developments
          11.20.6. SWOT Analysis
    11.21. SleepMed Inc.
          11.21.1. Business Overview
          11.21.2. Company Snapshot
          11.21.3. Company Market Share Analysis
          11.21.4. Company Product Portfolio
          11.21.5. Recent Developments
          11.21.6. SWOT Analysis
    11.22. Simple Habit
          11.22.1. Business Overview
          11.22.2. Company Snapshot
          11.22.3. Company Market Share Analysis
          11.22.4. Company Product Portfolio
          11.22.5. Recent Developments
          11.22.6. SWOT Analysis
    11.23. StimScience
          11.23.1. Business Overview
          11.23.2. Company Snapshot
          11.23.3. Company Market Share Analysis
          11.23.4. Company Product Portfolio
          11.23.5. Recent Developments
          11.23.6. SWOT Analysis
    11.24. Takeda Pharmaceutical Company Limited
          11.24.1. Business Overview
          11.24.2. Company Snapshot
          11.24.3. Company Market Share Analysis
          11.24.4. Company Product Portfolio
          11.24.5. Recent Developments
          11.24.6. SWOT Analysis
 

List of Table

1. Global Sleep Aids Market, By Product, 2019-2032 (USD Billion)

2. Global Mattresses & Pillows Sleep Aids, Sleep Aids Market, By Region, 2019-2032 (USD Billion)

3. Global Medications Sleep Aids, Sleep Aids Market, By Region, 2019-2032 (USD Billion)

4. Global Sleep Apnea Devices Sleep Aids, Sleep Aids Market, By Region, 2019-2032 (USD Billion)

5. Global Others Sleep Aids, Sleep Aids Market, By Region, 2019-2032 (USD Billion)

6. Global Sleep Aids Market, By Sleep Disorder, 2019-2032 (USD Billion)

7. Global Insomnia Sleep Aids Market, By Region, 2019-2032 (USD Billion)

8. Global Narcolepsy Sleep Aids Market, By Region, 2019-2032 (USD Billion)

9. Global Restless Leg Syndrome Sleep Aids Market, By Region, 2019-2032 (USD Billion)

10. Global Sleep Apnea Sleep Aids Market, By Region, 2019-2032 (USD Billion)

11. Global Others Sleep Aids Market, By Region, 2019-2032 (USD Billion)

12. Global Sleep Aids Market, By Distribution Channel, 2019-2032 (USD Billion)

13. Global Hospital Pharmacies Sleep Aids Market, By Region, 2019-2032 (USD Billion)

14. Global Retail Pharmacies Sleep Aids Market, By Region, 2019-2032 (USD Billion)

15. Global E-commerce Sleep Aids Market, By Region, 2019-2032 (USD Billion)

16. Global Drug Stores Sleep Aids Market, By Region, 2019-2032 (USD Billion)

17. Global Others Sleep Aids Market, By Region, 2019-2032 (USD Billion)

18. Global Sleep Aids Market, By Region, 2019-2032 (USD Billion)

19. North America Sleep Aids Market, By Product, 2019-2032 (USD Billion)

20. North America Sleep Aids Market, By Sleep Disorder, 2019-2032 (USD Billion)

21. North America Sleep Aids Market, By Distribution Channel, 2019-2032 (USD Billion)

22. U.S. Sleep Aids Market, By Product, 2019-2032 (USD Billion)

23. U.S. Sleep Aids Market, By Sleep Disorder, 2019-2032 (USD Billion)

24. U.S. Sleep Aids Market, By Distribution Channel, 2019-2032 (USD Billion)

25. Canada Sleep Aids Market, By Product, 2019-2032 (USD Billion)

26. Canada Sleep Aids Market, By Sleep Disorder, 2019-2032 (USD Billion)

27. Canada Sleep Aids Market, By Distribution Channel, 2019-2032 (USD Billion)

28. Mexico Sleep Aids Market, By Product, 2019-2032 (USD Billion)

29. Mexico Sleep Aids Market, By Sleep Disorder, 2019-2032 (USD Billion)

30. Mexico Sleep Aids Market, By Distribution Channel, 2019-2032 (USD Billion)

31. Europe Sleep Aids Market, By Product, 2019-2032 (USD Billion)

32. Europe Sleep Aids Market, By Sleep Disorder, 2019-2032 (USD Billion)

33. Europe Sleep Aids Market, By Distribution Channel, 2019-2032 (USD Billion)

34. Germany Sleep Aids Market, By Product, 2019-2032 (USD Billion)

35. Germany Sleep Aids Market, By Sleep Disorder, 2019-2032 (USD Billion)

36. Germany Sleep Aids Market, By Distribution Channel, 2019-2032 (USD Billion)

37. France Sleep Aids Market, By Product, 2019-2032 (USD Billion)

38. France Sleep Aids Market, By Sleep Disorder, 2019-2032 (USD Billion)

39. France Sleep Aids Market, By Distribution Channel, 2019-2032 (USD Billion)

40. U.K. Sleep Aids Market, By Product, 2019-2032 (USD Billion)

41. U.K. Sleep Aids Market, By Sleep Disorder, 2019-2032 (USD Billion)

42. U.K. Sleep Aids Market, By Distribution Channel, 2019-2032 (USD Billion)

43. Italy Sleep Aids Market, By Product, 2019-2032 (USD Billion)

44. Italy Sleep Aids Market, By Sleep Disorder, 2019-2032 (USD Billion)

45. Italy Sleep Aids Market, By Distribution Channel, 2019-2032 (USD Billion)

46. Spain Sleep Aids Market, By Product, 2019-2032 (USD Billion)

47. Spain Sleep Aids Market, By Sleep Disorder, 2019-2032 (USD Billion)

48. Spain Sleep Aids Market, By Distribution Channel, 2019-2032 (USD Billion)

49. Asia Pacific Sleep Aids Market, By Product, 2019-2032 (USD Billion)

50. Asia Pacific Sleep Aids Market, By Sleep Disorder, 2019-2032 (USD Billion)

51. Asia Pacific Sleep Aids Market, By Distribution Channel, 2019-2032 (USD Billion)

52. Japan Sleep Aids Market, By Product, 2019-2032 (USD Billion)

53. Japan Sleep Aids Market, By Sleep Disorder, 2019-2032 (USD Billion)

54. Japan Sleep Aids Market, By Distribution Channel, 2019-2032 (USD Billion)

55. China Sleep Aids Market, By Product, 2019-2032 (USD Billion)

56. China Sleep Aids Market, By Sleep Disorder, 2019-2032 (USD Billion)

57. China Sleep Aids Market, By Distribution Channel, 2019-2032 (USD Billion)

58. India Sleep Aids Market, By Product, 2019-2032 (USD Billion)

59. India Sleep Aids Market, By Sleep Disorder, 2019-2032 (USD Billion)

60. India Sleep Aids Market, By Distribution Channel, 2019-2032 (USD Billion)

61. South America Sleep Aids Market, By Product, 2019-2032 (USD Billion)

62. South America Sleep Aids Market, By Sleep Disorder, 2019-2032 (USD Billion)

63. South America Sleep Aids Market, By Distribution Channel, 2019-2032 (USD Billion)

64. Brazil Sleep Aids Market, By Product, 2019-2032 (USD Billion)

65. Brazil Sleep Aids Market, By Sleep Disorder, 2019-2032 (USD Billion)

66. Brazil Sleep Aids Market, By Distribution Channel, 2019-2032 (USD Billion)

67. Middle East and Africa Sleep Aids Market, By Product, 2019-2032 (USD Billion)

68. Middle East and Africa Sleep Aids Market, By Sleep Disorder, 2019-2032 (USD Billion)

69. Middle East and Africa Sleep Aids Market, By Distribution Channel, 2019-2032 (USD Billion)

70. UAE Sleep Aids Market, By Product, 2019-2032 (USD Billion)

71. UAE Sleep Aids Market, By Sleep Disorder, 2019-2032 (USD Billion)

72. UAE Sleep Aids Market, By Distribution Channel, 2019-2032 (USD Billion)

73. South Africa Sleep Aids Market, By Product, 2019-2032 (USD Billion)

74. South Africa Sleep Aids Market, By Sleep Disorder, 2019-2032 (USD Billion)

75. South Africa Sleep Aids Market, By Distribution Channel, 2019-2032 (USD Billion)

List of Figures 

1. Global Sleep Aids Market Segmentation

2. Sleep Aids Market: Research Methodology

3. Market Size Estimation Methodology: Bottom-Up Approach

4. Market Size Estimation Methodology: Top-Down Approach

5. Data Triangulation

6. Porter’s Five Forces Analysis 

7. Value Chain Analysis 

8. Global Sleep Aids Market Attractiveness Analysis by Product

9. Global Sleep Aids Market Attractiveness Analysis by Sleep Disorder

10. Global Sleep Aids Market Attractiveness Analysis by Distribution Channel

11. Global Sleep Aids Market Attractiveness Analysis by Region

12. Global Sleep Aids Market: Dynamics

13. Global Sleep Aids Market Share by Product (2023 & 2032)

14. Global Sleep Aids Market Share by Sleep Disorder (2023 & 2032)

15. Global Sleep Aids Market Share by Distribution Channel (2023 & 2032)

16. Global Sleep Aids Market Share by Regions (2023 & 2032)

17. Global Sleep Aids Market Share by Company (2022)

This study forecasts revenue at global, regional, and country levels from 2019 to 2032. The Brainy Insights has segmented the global sleep aids market based on below-mentioned segments:

Global Sleep Aids Market by Product:

  • Mattresses & Pillows   
  • Medications
  • Sleep Apnea Devices
  • Others

Global Sleep Aids Market by Sleep Disorder:

  • Insomnia     
  • Narcolepsy
  • Restless Leg Syndrome
  • Sleep Apnea
  • Others

Global Sleep Aids Market by Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • E-commerce         
  • Drug Stores
  • Others

Global Sleep Aids Market by Region:

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
  • Asia-Pacific
    • Japan
    • China
    • India
  • South America
    • Brazil
  • Middle East and Africa  
    • UAE
    • South Africa

Methodology

Research has its special purpose to undertake marketing efficiently. In this competitive scenario, businesses need information across all industry verticals; the information about customer wants, market demand, competition, industry trends, distribution channels etc. This information needs to be updated regularly because businesses operate in a dynamic environment. Our organization, The Brainy Insights incorporates scientific and systematic research procedures in order to get proper market insights and industry analysis for overall business success. The analysis consists of studying the market from a miniscule level wherein we implement statistical tools which helps us in examining the data with accuracy and precision. 

Our research reports feature both; quantitative and qualitative aspects for any market. Qualitative information for any market research process are fundamental because they reveal the customer needs and wants, usage and consumption for any product/service related to a specific industry. This in turn aids the marketers/investors in knowing certain perceptions of the customers. Qualitative research can enlighten about the different product concepts and designs along with unique service offering that in turn, helps define marketing problems and generate opportunities. On the other hand, quantitative research engages with the data collection process through interviews, e-mail interactions, surveys and pilot studies. Quantitative aspects for the market research are useful to validate the hypotheses generated during qualitative research method, explore empirical patterns in the data with the help of statistical tools, and finally make the market estimations.

The Brainy Insights offers comprehensive research and analysis, based on a wide assortment of factual insights gained through interviews with CXOs and global experts and secondary data from reliable sources. Our analysts and industry specialist assume vital roles in building up statistical tools and analysis models, which are used to analyse the data and arrive at accurate insights with exceedingly informative research discoveries. The data provided by our organization have proven precious to a diverse range of companies, facilitating them to address issues such as determining which products/services are the most appealing, whether or not customers use the product in the manner anticipated, the purchasing intentions of the market and many others.

Our research methodology encompasses an idyllic combination of primary and secondary initiatives. Key phases involved in this process are listed below:

MARKET RESEARCH PROCESS

Data Procurement:

The phase involves the gathering and collecting of market data and its related information with the help of different sources & research procedures.

The data procurement stage involves in data gathering and collecting through various data sources.

This stage involves in extensive research. These data sources includes:

Purchased Database: Purchased databases play a crucial role in estimating the market sizes irrespective of the domain. Our purchased database includes:

  • The organizational databases such as D&B Hoovers, and Bloomberg that helps us to identify the competitive scenario of the key market players/organizations along with the financial information.
  • Industry/Market databases such as Statista, and Factiva provides market/industry insights and deduce certain formulations. 
  • We also have contractual agreements with various reputed data providers and third party vendors who provide information which are not limited to:
    • Import & Export Data
    • Business Trade Information
    • Usage rates of a particular product/service on certain demographics mainly focusing on the unmet prerequisites

Primary Research: The Brainy Insights interacts with leading companies and experts of the concerned domain to develop the analyst team’s market understanding and expertise. It improves and substantiates every single data presented in the market reports. Primary research mainly involves in telephonic interviews, E-mail interactions and face-to-face interviews with the raw material providers, manufacturers/producers, distributors, & independent consultants. The interviews that we conduct provides valuable data on market size and industry growth trends prevailing in the market. Our organization also conducts surveys with the various industry experts in order to gain overall insights of the industry/market. For instance, in healthcare industry we conduct surveys with the pharmacists, doctors, surgeons and nurses in order to gain insights and key information of a medical product/device/equipment which the customers are going to usage. Surveys are conducted in the form of questionnaire designed by our own analyst team. Surveys plays an important role in primary research because surveys helps us to identify the key target audiences of the market. Additionally, surveys helps to identify the key target audience engaged with the market. Our survey team conducts the survey by targeting the key audience, thus gaining insights from them. Based on the perspectives of the customers, this information is utilized to formulate market strategies. Moreover, market surveys helps us to understand the current competitive situation of the industry. To be precise, our survey process typically involve with the 360 analysis of the market. This analytical process begins by identifying the prospective customers for a product or service related to the market/industry to obtain data on how a product/service could fit into customers’ lives.

Secondary Research: The secondary data sources includes information published by the on-profit organizations such as World bank, WHO, company fillings, investor presentations, annual reports, national government documents, statistical databases, blogs, articles, white papers and others. From the annual report, we analyse a company’s revenue to understand the key segment and market share of that organization in a particular region. We analyse the company websites and adopt the product mapping technique which is important for deriving the segment revenue. In the product mapping method, we select and categorize the products offered by the companies catering to domain specific market, deduce the product revenue for each of the companies so as to get overall estimation of the market size. We also source data and analyses trends based on information received from supply side and demand side intermediaries in the value chain. The supply side denotes the data gathered from supplier, distributor, wholesaler and the demand side illustrates the data gathered from the end customers for respective market domain.

The supply side for a domain specific market is analysed by:

  • Estimating and projecting penetration rates through analysing product attributes, availability of internal and external substitutes, followed by pricing analysis of the product.
  • Experiential assessment of year-on-year sales of the product by conducting interviews.

The demand side for the market is estimated through:

  • Evaluating the penetration level and usage rates of the product.
  • Referring to the historical data to determine the growth rate and evaluate the industry trends

In-house Library: Apart from these third-party sources, we have our in-house library of qualitative and quantitative information. Our in-house database includes market data for various industry and domains. These data are updated on regular basis as per the changing market scenario. Our library includes, historic databases, internal audit reports and archives.

Sometimes there are instances where there is no metadata or raw data available for any domain specific market. For those cases, we use our expertise to forecast and estimate the market size in order to generate comprehensive data sets. Our analyst team adopt a robust research technique in order to produce the estimates:

  • Applying demographic along with psychographic segmentation for market evaluation
  • Determining the Micro and Macro-economic indicators for each region 
  • Examining the industry indicators prevailing in the market. 

Data Synthesis: This stage involves the analysis & mapping of all the information obtained from the previous step. It also involves in scrutinizing the data for any discrepancy observed while data gathering related to the market. The data is collected with consideration to the heterogeneity of sources. Robust scientific techniques are in place for synthesizing disparate data sets and provide the essential contextual information that can orient market strategies. The Brainy Insights has extensive experience in data synthesis where the data passes through various stages:

  • Data Screening: Data screening is the process of scrutinising data/information collected from primary research for errors and amending those collected data before data integration method. The screening involves in examining raw data, identifying errors and dealing with missing data. The purpose of the data screening is to ensure data is correctly entered or not. The Brainy Insights employs objective and systematic data screening grades involving repeated cycles of quality checks, screening and suspect analysis.
  • Data Integration: Integrating multiple data streams is necessary to produce research studies that provide in-depth picture to the clients. These data streams come from multiple research studies and our in house database. After screening of the data, our analysts conduct creative integration of data sets, optimizing connections between integrated surveys and syndicated data sources. There are mainly 2 research approaches that we follow in order to integrate our data; top down approach and bottom up approach.

Market Deduction & Formulation: The final stage comprises of assigning data points at appropriate market spaces so as to deduce feasible conclusions. Analyst perspective & subject matter expert based holistic form of market sizing coupled with industry analysis also plays a crucial role in this stage.

This stage involves in finalization of the market size and numbers that we have collected from data integration step. With data interpolation, it is made sure that there is no gap in the market data. Successful trend analysis is done by our analysts using extrapolation techniques, which provide the best possible forecasts for the market.

Data Validation & Market Feedback: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helps us finalize data-points to be used for final calculations.

The Brainy Insights interacts with leading companies and experts of the concerned domain to develop the analyst team’s market understanding and expertise. It improves and substantiates every single data presented in the market reports. The data validation interview and discussion panels are typically composed of the most experienced industry members. The participants include, however, are not limited to:

  • CXOs and VPs of leading companies’ specific to sector
  • Purchasing managers, technical personnel, end-users
  • Key opinion leaders such as investment bankers, and industry consultants

Moreover, we always validate our data and findings through primary respondents from all the major regions we are working on.

Some Facts About The Brainy Insights

50%

Free Customization

300+

Fortune 500 Clients

1

Free Yearly Update On Purchase Of Multi/Corporate License

900+

Companies Served Till Date